Replies to post #176 on ViroPharma Incorporated (VPHM)

[surf1944]

6:11AM ViroPharma announces positive CHMP opinion for Buccolam in the European Union (VPHM) 17.95 : Co announced that The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of a Pediatric Use Marketing Authorization for Buccolam, for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years. If approved by the European Commission, Buccolam would be the first product approved through the centralized PUMA procedure.